EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedTech Solutions's EBITDA for the
three
months ended in Mar. 2026 was zł-0.33 Mil. MedTech Solutions's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, MedTech Solutions's EBITDA margin for the quarter that ended in Mar. 2026 was -8,350.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MedTech Solutions EBITDA Margin % Related Terms
MedTech Solutions EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for MedTech Solutions's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:MDT vs AMZN, BABA, PDD: EBITDA Margin % Comparison
For the Internet Retail subindustry, MedTech Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedTech Solutions EBITDA Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MedTech Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Solutions (WAR:MDT) has a EBITDA Margin % of -8,350.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedTech Solutions and its competitors. According to the industry distribution chart, MedTech Solutions ranks #1126 out of 1128 companies in the Retail - Cyclical industry, placing it in the top 99.8%.
Is MedTech Solutions' EBITDA Margin % too high?
MedTech Solutions' current EBITDA Margin % is -8,350.00%. Based on the distribution chart, MedTech Solutions ranks #1126 out of 1128 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, MedTech Solutions has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' EBITDA Margin % compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, MedTech Solutions ranks #1126 out of 1128 companies for EBITDA Margin %. This places MedTech Solutions in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Retail - Cyclical company?
The median EBITDA Margin % among Retail - Cyclical companies is 7.48, based on 1,128 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedTech Solutions and its competitors. For the Retail - Cyclical industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedTech Solutions's current EBITDA Margin % is -8,350.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.04, compared to a current price of zł0.38 — trading 860% above its estimated fair value. The current EBITDA Margin % is -8,350.00%. MedTech Solutions' overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current EBITDA Margin % is -8,350.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedTech Solutions (WAR:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued.
The current stock price of zł0.38 is trading 860% above its estimated GF Value™ of zł0.04.
GuruFocus considers MedTech Solutions to be Significantly Overvalued.
Key valuation signals for WAR:MDT:
EBITDA Margin %: -8,350.00%
GF Value™: zł0.04 vs. price of zł0.38 (860% above fair value)
No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
28GF Score
Get the complete analysis for WAR:MDT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MDT has been successfully added to your 
